171 related articles for article (PubMed ID: 38398332)
1. Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study.
Vernero M; Saibeni S; Scalvini D; Cicalini C; Chiarello L; Nardi S; Ribaldone DG; Bezzio C
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398332
[No Abstract] [Full Text] [Related]
2. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations.
Bezzio C; Della Corte C; Vernero M; Di Luna I; Manes G; Saibeni S
Therap Adv Gastroenterol; 2022; 15():17562848221115312. PubMed ID: 35924080
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
Attauabi M; Zhao M; Bendtsen F; Burisch J
Inflamm Bowel Dis; 2021 May; 27(6):927-939. PubMed ID: 32628745
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.
Akiyama S; Fukuda S; Steinberg JM; Suzuki H; Tsuchiya K
World J Gastroenterol; 2022 Jul; 28(25):2843-2853. PubMed ID: 35978883
[TBL] [Abstract][Full Text] [Related]
7. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.
Attauabi M; Wewer MD; Bendtsen F; Seidelin JB; Burisch J
Inflamm Bowel Dis; 2022 Nov; 28(11):1756-1765. PubMed ID: 35134921
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
10. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration.
Tavakoli P; Vollmer-Conna U; Hadzi-Pavlovic D; Grimm MC
Public Health Rev; 2021; 42():1603990. PubMed ID: 34692176
[No Abstract] [Full Text] [Related]
11. Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach.
García MJ; Pascual M; Del Pozo C; Díaz-González A; Castro B; Rasines L; Crespo J; Rivero M
Sci Rep; 2020 Jul; 10(1):10731. PubMed ID: 32612137
[TBL] [Abstract][Full Text] [Related]
12. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
13. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
[TBL] [Abstract][Full Text] [Related]
14. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.
Barrie A; Regueiro M
Inflamm Bowel Dis; 2007 Nov; 13(11):1424-9. PubMed ID: 17567879
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical features of patients with autoimmune pancreatitis and inflammatory bowel disease: A systematic review and meta-analysis.
Fukuda S; Akiyama S; Tarakji A; Hamdeh S; Suzuki H; Tsuchiya K
J Gastroenterol Hepatol; 2022 Aug; 37(8):1474-1484. PubMed ID: 35596263
[TBL] [Abstract][Full Text] [Related]
16. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
Rogler G; Singh A; Kavanaugh A; Rubin DT
Gastroenterology; 2021 Oct; 161(4):1118-1132. PubMed ID: 34358489
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X
Front Immunol; 2023; 14():1234535. PubMed ID: 37954590
[TBL] [Abstract][Full Text] [Related]
18. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
Card TR; Langan SM; Chu TP
Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
[TBL] [Abstract][Full Text] [Related]
19. Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey.
Vernero M; Bezzio C; Ribaldone DG; Caprioli FA; Fantini MC; Festa S; Macaluso FS; Orlando A; Pugliese D; Renna S; Rispo A; Savarino EV; Variola A; Saibeni S;
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610623
[TBL] [Abstract][Full Text] [Related]
20. Immune-mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis.
Vuyyuru SK; Kedia S; Sahu P; Ahuja V
JGH Open; 2022 Feb; 6(2):100-111. PubMed ID: 35155819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
